Shockwave Medical, Inc. Aktie News

Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (JNJ) announced it would buy the company for $12.5 billion, boosting its portfolio of cardiovascular disease treatment devices.

MILWAUKEE, April 5, 2024 /PRNewswire/-- Ademi LLP is investigating Shockwave (Nasdaq: SWAV) for possible breaches of fiduciary duty and other violations of law in its transaction with Johnson & Johnson. Click here to learn how to join the https://www.ademilaw.com/case/shockwave-medical-inc or call Guri Ademi toll-free at 866-264-3995.

The healthcare giant said the addition of the medical-device maker would expand its MedTech cardiovascular portfolio.

Johnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years as it expands on cardiovascular intervention.

Johnson & Johnson (NYSE: JNJ ) is buying medical device company Shockwave Medical (NASDAQ: SWAV ) for $13.1 billion. Shockwave makes devices that perform Intravascular Lithotripsy.

Johnson & Johnson will pay $13.1 billion, or $335 a share, for Shockwave Medical, which has soared in 2024 in part on takeover speculation.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Shockwave Medical, Inc. (NASDAQ: SWAV) to Johnson & Johnson for $335.00 per share in cash is fair to Shockwave shareholders. Halper Sadeh encourages Shockwave shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212...

Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premium The all-cash agreement values each share of Shockwave Medical at $335 – a 5.0% premium on their previous close.